Cargando…

A Novel Six-mRNA Signature Predicts Survival of Patients With Glioblastoma Multiforme

Glioblastoma multiforme (GBM) is a devastating brain tumor and displays divergent clinical outcomes due to its high degree of heterogeneity. Reliable prognostic biomarkers are urgently needed for improving risk stratification and survival prediction. In this study, we analyzed genome-wide mRNA profi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhentao, Zhang, Hao, Hu, Hongkang, Cai, Zheng, Lu, Chengyin, Liang, Qiang, Qian, Jun, Wang, Chunhui, Jiang, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006298/ https://www.ncbi.nlm.nih.gov/pubmed/33790946 http://dx.doi.org/10.3389/fgene.2021.634116

Ejemplares similares

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
por: Gao, Ming, et al.
Publicado: (2021)

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
por: Yang, Ji’an, et al.
Publicado: (2020)

Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
por: Tang, Xiangjun, et al.
Publicado: (2020)

Network Signatures of Survival in Glioblastoma Multiforme
por: Patel, Vishal N., et al.
Publicado: (2013)

An Integrated mRNA and microRNA Expression Signature for Glioblastoma Multiforme Prognosis
por: Xiong, Jie, et al.
Publicado: (2014)

Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme
por: Sun, Ruohan, et al.
Publicado: (2021)

Regulatory pattern of abnormal promoter CpG island methylation in the glioblastoma multiforme classification
por: Wang, Rendong, et al.
Publicado: (2022)

Immunogenomic Profiling Demonstrate AC003092.1 as an Immune-Related eRNA in Glioblastoma Multiforme
por: Guo, Xiao-Yu, et al.
Publicado: (2021)

Distinguishing Glioblastoma Subtypes by Methylation Signatures
por: Zhang, Yu-Hang, et al.
Publicado: (2020)

Identification of a Five-mRNA Signature as a Novel Potential Prognostic Biomarker for Glioblastoma by Integrative Analysis
por: Xu, Huifang, et al.
Publicado: (2022)

Network pharmacological analysis of active components of Xiaoliu decoction in the treatment of glioblastoma multiforme
por: Wu, Ji, et al.
Publicado: (2022)

IGFBP2 Is a Potential Master Regulator Driving the Dysregulated Gene Network Responsible for Short Survival in Glioblastoma Multiforme
por: Kalya, Manasa, et al.
Publicado: (2021)

A 6-Gene Risk Signature Predicts Survival of Glioblastoma Multiforme
por: Zhao, Jingwei, et al.
Publicado: (2019)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

A Novel Glycolysis-Related Four-mRNA Signature for Predicting the Survival of Patients With Breast Cancer
por: Zhang, Xiaolu, et al.
Publicado: (2021)

Construction of Potential Glioblastoma Multiforme-Related miRNA-mRNA Regulatory Network
por: Lou, Weiyang, et al.
Publicado: (2019)

Differential Expression of Circular RNAs in Glioblastoma Multiforme and Its Correlation with Prognosis()
por: Zhu, Junle, et al.
Publicado: (2017)

Comprehensive development and validation of gene signature for predicting survival in patients with glioblastoma
por: Jin, Yi, et al.
Publicado: (2022)

An expression based REST signature predicts patient survival and therapeutic response for glioblastoma multiforme
por: Liang, Jianfeng, et al.
Publicado: (2016)

Exploring the prognostic value of HK3 and its association with immune infiltration in glioblastoma multiforme
por: Yang, Yuling, et al.
Publicado: (2023)

miRNA–mRNA Associated With Survival in Endometrial Cancer
por: Xu, Xiaofeng, et al.
Publicado: (2019)

A Pan-Cancer Analysis of Transcriptome and Survival Reveals Prognostic Differentially Expressed LncRNAs and Predicts Novel Drugs for Glioblastoma Multiforme Therapy
por: Zhao, Rongchuan, et al.
Publicado: (2021)

Signatures of mRNA Alternative Polyadenylation in Arabidopsis Leaf Development
por: Yu, Zhibo, et al.
Publicado: (2022)

Identification of Tumor Antigens and Immune Landscape in Glioblastoma for mRNA Vaccine Development
por: Ye, Liguo, et al.
Publicado: (2021)

Identification of mRNA Signature for Predicting Prognosis Risk of Rectal Adenocarcinoma
por: Jiang, Linlin, et al.
Publicado: (2022)

Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2016)

Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients
por: Gao, Wei-Zhen, et al.
Publicado: (2018)

Immunophenotypic signature of primary glioblastoma multiforme: A case of extended progression free survival
por: Gandhi, Puneet, et al.
Publicado: (2017)

A risk signature with four autophagy‐related genes for predicting survival of glioblastoma multiforme
por: Wang, Yulin, et al.
Publicado: (2020)

MRI Manifestions Correlate with Survival of Glioblastoma Multiforme Patients
por: Li, Wen-bin, et al.
Publicado: (2012)

Six-lncRNA Immune Prognostic Signature for Cervical Cancer
por: Chen, Qian, et al.
Publicado: (2020)

Longevity-Related Gene Transcriptomic Signature in Glioblastoma Multiforme
por: Fawzy, Manal S., et al.
Publicado: (2018)

Identifying Differential Expression Genes and Prognostic Signature Based on Subventricular Zone Involved Glioblastoma
por: Yuan, Qing, et al.
Publicado: (2022)

An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2020)

A genetic survival network for glioblastoma multiforme
por: Lin, Andy, et al.
Publicado: (2011)

Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer
por: Xu, Fei, et al.
Publicado: (2021)

Glioblastoma Multiforme Oncogenomics and Signaling Pathways
por: Kanu, Okezie O., et al.
Publicado: (2009)

MicroRNA Expression Signatures Determine Prognosis and Survival in Glioblastoma Multiforme—a Systematic Overview
por: Henriksen, Michael, et al.
Publicado: (2014)

Prognostic lncRNA, miRNA, and mRNA Signatures in Papillary Thyroid Carcinoma
por: Wang, Kun, et al.
Publicado: (2020)

Development of a Four-mRNA Expression-Based Prognostic Signature for Cutaneous Melanoma
por: Bai, Haiya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_arg41jg2b1eo490cvquhbkchr5